Congress Looks to Beef up Agency’s Power to Withdraw Unproven AA Drugs
The House Energy and Commerce Committee is considering a pair of rival bills, one Democratic and one Republican, to reform the AA process.
Recent Headlines
The House Energy and Commerce Committee is considering a pair of rival bills, one Democratic and one Republican, to reform the AA process.
A recent study shows these tests may make it easier and more cost-effective to identify patients for studies of new PET treatments.
Legislation would require Medicare to cover genomic cancer testing and follow-up screening for those with a family history of cancer.
Could paying the tuition costs of employees seeking certification put you at risk of violating the AKS?
CMS recently announced some important changes affecting PAMA price reporting, along with a list of 17 new PLA codes that will be recognized.
On Jan. 11, the FDA warned consumers not to use COVID-19 tests from LuSys Laboratories, as they have not been approved for use in the US.
Recent case shows that you better respond promptly when patients request access to their medical records.